Image-guided therapy developer ViewRay received the CE Mark for its next-generation linear accelerator-based MRI-guided radiation therapy system, the MRIdian Linac.
The MRIdian Linac builds on the first-generation MRIdian system but replaces cobalt with linear accelerator technology.
In addition to receiving the CE Mark for the MRIdian Linac in Europe, the company has also submitted its 510(k) application for the MRIdian Linac technology in the U.S., the firm said.
